Axcelis Technologies, Inc. (NASDAQ:ACLS) Stock Has Consensus Price Target of $148.67

Key Points

• Analysts maintain a “Hold” consensus on Axcelis Technologies, with one sell, three hold and one buy rating. The average 12-month price target is $148.67, close to the reported share price of $147.77.
• Axcelis exceeded quarterly expectations, reporting $1.06 in EPS versus the $0.89 consensus and revenue of $215.18 million versus $205.03 million expected. Revenue increased 10.6% year over year.
• Institutional investors own approximately 89.98% of the company. Axcelis develops ion-implantation equipment used by semiconductor manufacturers to produce chips.

Shares of Axcelis Technologies, Inc. (NASDAQ:ACLS - Get Free Report) have earned a consensus recommendation of "Hold" from the five research firms that are currently covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and one has given a buy rating to the company. The average 1 year price target among brokerages that have updated their coverage on the stock in the last year is $148.67.

ACLS has been the subject of several recent analyst reports. Bank of America raised their target price on shares of Axcelis Technologies from $130.00 to $156.00 and gave the company an "underperform" rating in a research note on Tuesday, June 23rd. Weiss Ratings reiterated a "hold (c-)" rating on shares of Axcelis Technologies in a report on Friday, August 7th. Finally, Craig Hallum cut Axcelis Technologies from a "buy" rating to a "hold" rating and set a $140.00 price objective for the company. in a research report on Friday, August 7th.

Axcelis Technologies Price Performance

Shares of ACLS stock opened at $147.77 on Monday. The stock's 50-day moving average is $123.60 and its 200 day moving average is $134.44. Axcelis Technologies has a 1-year low of $73.60 and a 1-year high of $193.78. The company has a debt-to-equity ratio of 0.04, a current ratio of 4.90 and a quick ratio of 3.21. The company has a market cap of $4.56 billion, a P/E ratio of 49.59, a PEG ratio of 4.51 and a beta of 1.86.

Axcelis Technologies (NASDAQ:ACLS - Get Free Report) last announced its earnings results on Thursday, August 6th. The semiconductor company reported $1.06 EPS for the quarter, topping analysts' consensus estimates of $0.89 by $0.17. Axcelis Technologies had a net margin of 10.71% and a return on equity of 11.69%. The business had revenue of $215.18 million during the quarter, compared to the consensus estimate of $205.03 million. During the same period in the previous year, the company posted $1.13 earnings per share. The firm's revenue was up 10.6% on a year-over-year basis. Axcelis Technologies has set its Q3 2026 guidance at 1.110-1.110 EPS. Research analysts predict that Axcelis Technologies will post 3.39 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Axcelis Technologies

Several institutional investors have recently added to or reduced their stakes in the business. Parallel Advisors LLC increased its holdings in shares of Axcelis Technologies by 22.0% during the first quarter. Parallel Advisors LLC now owns 665 shares of the semiconductor company's stock valued at $62,000 after acquiring an additional 120 shares in the last quarter. Public Employees Retirement System of Ohio acquired a new stake in Axcelis Technologies in the 2nd quarter worth approximately $82,000. Ancora Advisors LLC purchased a new stake in Axcelis Technologies during the 2nd quarter worth approximately $95,000. Rockefeller Capital Management L.P. grew its position in Axcelis Technologies by 69.2% during the 4th quarter. Rockefeller Capital Management L.P. now owns 1,357 shares of the semiconductor company's stock worth $109,000 after purchasing an additional 555 shares during the last quarter. Finally, NewEdge Advisors LLC increased its stake in Axcelis Technologies by 247.9% during the 2nd quarter. NewEdge Advisors LLC now owns 581 shares of the semiconductor company's stock valued at $110,000 after purchasing an additional 414 shares in the last quarter. Institutional investors and hedge funds own 89.98% of the company's stock.

About Axcelis Technologies

Axcelis Technologies, Inc NASDAQ: ACLS develops and manufactures equipment used in semiconductor fabrication. The company's primary business is ion implantation, a process that modifies the electrical properties of silicon and other semiconductor materials by introducing controlled amounts of dopants. Its systems are used by chip manufacturers to produce a range of semiconductor devices.

Axcelis offers the Purion family of ion implantation systems, including platforms designed for high-current, medium-current and high-energy applications.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.